We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

443060:KRXHD Hyundai Marine Solution Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

₩173,100.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

HDHMS is trading at 173,100 KRW, which sits just below its 20‑day SMA (174,740 KRW) and well under the 50‑day (181,678 KRW) and 200‑day (197,333 KRW) averages, signalling a short‑term bearish bias. However, the MACD histogram has turned positive (≈405) while the MACD line has crossed above its signal line, offering a bullish technical hint, and the RSI at 47 is comfortably away from overbought levels. Volatility is elevated at roughly 65 % over the past month, but the stock’s beta of 0.59 suggests lower market‑wide sensitivity. Fundamentally, the company posted 11 % revenue growth, robust gross (22 %) and operating margins (18 %), and an exceptional ROE of 36 %, all underpinned by a massive cash pile (≈517 B KRW) versus modest debt. The dividend yield of 3.84 % and an 81 % payout ratio provide attractive income, yet the DCF‑derived fair value of about 105 k KRW places the current price well above intrinsic estimates, flagging potential overvaluation. Relative valuation appears mixed: a forward P/E of 22 is below the industry average of 29, and analyst consensus targets (≈250‑260 k KRW) imply a 48 % upside, aligning with the technical resistance at 188,800 KRW. In sum, the stock blends strong cash‑generating fundamentals and dividend appeal with a price that may be stretched, while technical signals hint at a possible near‑term bounce.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price just below short‑term moving averages
  • Bullish MACD crossover with neutral RSI
  • High volatility and limited liquidity

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong earnings growth and high ROE
  • Attractive dividend yield and payout ratio
  • Analyst price targets indicating ~48% upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained cash generation and defensive industry positioning
  • Potential overvaluation relative to DCF fair value
  • Stable dividend income supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth11.30%
Profit Margin13.70%
P/E Ratio22.1
ROE36.51%
ROA17.98%
Debt/Equity2.50
Op. Cash Flow₩276.5B
Free Cash Flow₩192.8B
Industry P/E29.1

Technical Analysis

TrendBearish
RSI47.3
Support₩158,000.00
Resistance₩188,800.00
MA 20₩174,740.00
MA 50₩181,678.00
MA 200₩197,333.00
MACDBullish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value₩105,252.04
Target Price₩256,666.67
Upside/Downside48.28%
GradeOvervalued
TypeBlend
Dividend Yield3.84%

Risk Assessment

Beta0.59
Volatility65.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.